Can a menopause drug alter breast cancer risk signals? small study explores.

This early study looked at whether a combination of two hormones (bazedoxifene and conjugated estrogen) could change breast MRI and mammogram readings in women ages 45-65 who have menopausal symptoms and a moderate risk of breast cancer. Only 16 women took part, and the main goal was to see if the study design was acceptable to participants. The results help researchers understand how these hormones might affect breast tissue, but no conclusions about cancer prevention or treatment can be drawn from this small pilot.